Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of May 2025. The report documents the convening of a Special General Meeting of Shareholders held on May 15, 2025, in Caesarea, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding shareholder voting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary event is the successful approval of all agenda items presented in the Proxy Statement filed on April 10, 2025.
Guidance, Outlook, and Risks
The filing confirms that a quorum was present and shareholders approved all agenda items by the required majority. It notes that this report is incorporated by reference into the Company's Registration Statements on Form F-3 and Form S-8. No specific management commentary, future guidance, risks, or contingencies are detailed in this text.
Key Facts for Investor Verification
- Shareholders approved all agenda items at the Special General Meeting on May 15, 2025.
- The specific details of the approved agenda items are located in the Proxy Statement (Exhibit 99.2) filed on April 10, 2025.
- This filing serves to update the Company's active Registration Statements on Form F-3 and Form S-8.
- No financial performance data is included in this specific report.